COMETRIQ is a prescription medicine used to treat people with medullary thyroid cancer (MTC) that has spread to other parts of the body (called metastatic MTC). It is not known if COMETRIQ is safe and effective in children.

COMETRIQ ® (cabozantinib) is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC) Attack from multiple angles. COMETRIQ has been shown to inhibit the activity of MET; VEGFR-1, -2, and -3; RET; and other receptor tyrosine kinases, in vitro 1

COMETRIQ is a prescription medicine used to treat people with medullary thyroid cancer (MTC) that has spread to other parts of the body (called metastatic MTC). It is not known if COMETRIQ is safe and effective in children.

0rqlwru sdwlhqwv iru v\pswrpv ri shuirudwlrqv dqg ilvwxodv lqfoxglqj devfhvv dqg vhsvlv 'lvfrqwlqxh &20(75,4 lq sdwlhqwv zkr h[shulhqfh d *udgh ilvwxod ru d *, shuirudwlrq >vhh

Get answers to frequently asked questions about COMETRIQ®, a treatment for people with medullary thyroid cancer (MTC) that has spread to other parts of the body. Important Safety Information For Healthcare Providers

COMETRIQ ® (cabozantinib) is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC). Please see full Prescribing Information . You are encouraged to report negative side effects of prescription drugs to the FDA.

Perform an oral examination prior to initiation of COMETRIQ and periodically during COMETRIQ treatment. Advise patients regarding good oral hygiene practices. Withhold COMETRIQ treatment for at least 3 weeks prior to scheduled dental surgery or invasive dental procedures, if possible.

COMETRIQ is a prescription medicine used to treat people with medullary thyroid cancer that has spread to other parts of the body. It is not known if COMETRIQ is safe and effective in children. Please see the Patient Information in the accompanying full Prescribing Information .

Learn about the kinds of side effects you might experience while taking COMETRIQ® to treat medullary thyroid cancer (MTC) that has spread to other parts of the body. Important Safety Information For Healthcare Providers

COMETRIQ is a prescription medicine used to treat people with medullary thyroid cancer that has spread to other parts of the body. It is not known if COMETRIQ is safe and effective in children. Please see the Patient Information in the accompanying full Prescribing Information .